Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001086364-13-001173
Filing Date
2013-01-30
Accepted
2013-01-30 14:30:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 cumberland.pharmaceuticals.txt SC 13G 11182
  Complete submission text file 0001086364-13-001173.txt   12875
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Subject) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-85205 | Film No.: 13558298
SIC: 2834 Pharmaceutical Preparations

Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 0226
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies